Evidence map›Paper›PMID 39177714›Full record

ArticleArchives of dermatological research2024

Investigation of the in-vitro lethal effect of spilanthol on demodex and finding the most effective dose.

Rabia Oztas Kara, Bahar Sevimli Dikicier, Berna Solak, Ozlem Aydemir, Ahmet Kara, Ayse Serap Karadag

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rabia Oztas KaraDepartment of Dermatology, School of Medicine, Sakarya University, Sakarya, Korucuk, 54100, Turkey. r.oztas.kara@gmail.com.ORCID http://orcid.org/0000-0003-1828-5844
Bahar Sevimli DikicierDepartment of Dermatology, School of Medicine, Sakarya University, Sakarya, Korucuk, 54100, Turkey.ORCID http://orcid.org/0000-0002-1912-3946
Berna SolakDepartment of Dermatology, School of Medicine, Sakarya University, Sakarya, Korucuk, 54100, Turkey.ORCID http://orcid.org/0000-0002-1683-2421
Ozlem AydemirDepartment of Medical Microbiology, School of Medicine, Sakarya University, Sakarya, Turkey.ORCID http://orcid.org/0000-0001-7482-3358
Ahmet KaraDepartment of Otorhinolaryngology, School of Medicine, Sakarya University, Sakarya, Turkey.ORCID http://orcid.org/0000-0003-3600-5957
Ayse Serap KaradagDepartment of Dermatology, School of Medicine, Istanbul Arel University, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-4333-8274

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Demodex species are associated with many dermatological diseases, so an acaricidal agent that is effective against them and safe for skin applications may benefit many diseases. This study aims to investigate the anti-demodex potential of spilanthol, a product obtained from the Spilanthes Acmella plant, by determining the minimal effective dose for the first time in the literature. Demodex mites were obtained from 70 patients with standard superficial skin biopsy. Spilanthol extract was used at 1%, 2%, 3%, 4%, and 5%. Standard immersion oil was used for the negative control, and permethrin 5% was used for the positive control group. The dependent variable is the survival time of the mite. Comparisons with the negative control group, the anti-demodex effect demonstrated itself in all groups, creating a statistically significant difference (p < 0.001). The positive control group, had 3%, 4%, and 5% spilanthol rates which were very similar to the results with 5% permethrin (p > 0.05). Higher concentrations than 3% did not make any additional contribution to survival times. This is the first attempt to show the dose-dependent acaricidal effect of spilanthol on demodex mites. Even the 3% dose shows similar results to 5% permethrin, and no additional effect increase was observed at higher doses. Therefore, in vivo, studies may be planned with a 3% spilanthol dose for further studies.

Indexed as

AcaricidesMite InfestationsMitesAnimalsDose-Response Relationship, DrugHumansPermethrinPolyunsaturated AlkamidesSkinAcaricidesN-isobutyl-2E-decenamidePermethrinPolyunsaturated AlkamidesDemodexMitePermethrinSpilanthol

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.